Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD...

25
Perspectives on Pathogen Perspectives on Pathogen Performance Standards Performance Standards Richard C. Whiting Richard C. Whiting FDA, CFSAN FDA, CFSAN College Park, MD College Park, MD 301-436-1925 301-436-1925 December 10, 2003 2003 SRA Annual Meeting

Transcript of Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD...

Page 1: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Perspectives on Pathogen Perspectives on Pathogen Performance StandardsPerformance Standards

Richard C. WhitingRichard C. WhitingFDA, CFSANFDA, CFSAN

College Park, MDCollege Park, MD301-436-1925301-436-1925

December 10, 2003

2003 SRA Annual Meeting

Page 2: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Traditional Performance Criteria(government specifications)

Poultry cooked to minimum of 165°FShellfish frozen < -35°C for 168 h for

parasitesWhole eggs pasteurized at 140°F for 3.5

minMilk pasteurized at 72°C for 15 secFood code safety criteria Aw < 0.95 & pH <

5.5 for Lm

5 log reduction of E. coli O157:H7 in juice

Page 3: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Traditional Performance Criteria

Major components in HACCP plans Critical control points

Not directly related to public health and the rate of illness

Inflexible, not conductive to innovation

Page 4: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Deterministic analysis

MC > Ho – Σ Rn + Σ In

Page 5: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Process risk assessment

Rawingredients StoragePasteurization Consumption Illness

Exposure assessment Hazard characterizationDose-response relationship

Risk characterization

Page 6: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Process risk assessment

Rawingredients StoragePasteurization Consumption Illness

Acceptable level ofprotection (cases/yr)Food safety objective

(cfu/g)Performance criteria (logs inactivation)Process criteria (C - min) ICMSF

Page 7: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Process risk assessment

Rawingredients Storage

PeriodsPasteurization Consumption Illness

Acceptable level of protection (cases/yr)Food safety objective

(cfu/g)Performance criteria (logs inactivation)Process criteria (C - min) ICMSF

Microbiological criteria(cfu/g)

Page 8: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Appropriate Level of Protection(ALOP)

Degree of risk that a society is willing to tolerate/accept

The “costs” that society is willing to bear to achieve a specific degree of control over a hazard“Costs” includes: human, quality,

nutritional, economic, ethical, medical, legal, etc

Page 9: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

ALOP

U.S. goal for 2005—less than 0.25 cases of listeriosis per 100,000 people per year

About 1 case per 1 million servings

Page 10: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Food Safety ObjectiveFSO

The maximum frequency and/or concentration of a microbial hazard in a food at the moment of consumption that provides the appropriate level of protection

Codex Committee Food Hygiene

Page 11: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Dose-Response Curve

0 4 8 12

Log Pathogen Cells Ingested

0.0

0.2

0.4

0.6

0.8

1.0

Pro

bab

ilit

y o

f Il

lnes

s

6 102

Page 12: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

0 4 8 12

Log Pathogen Cells Ingested

-10

-8

-6

-4

-2

0

Lo

g P

rob

abil

ity

of

Illn

ess

6 102

Dose-Response Curve

Page 13: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

0 4 8 12

Log (Pathogen Cells Ingested)

-10

-8

-6

-4

-2

0

Lo

g P

rob

abil

ity

of

Illn

ess

6 102

ALOP to FSO

ALOPs

FSOs

Page 14: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Food Safety Objective

FSO is a “line in the sand” FSO is a “line in the sand”

Articulates for a particular food the level of Articulates for a particular food the level of a specified pathogen that will not be a specified pathogen that will not be exceeded exceeded

Page 15: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Process risk assessment

Rawingredients Storage

PeriodsPasteurization Consumption Illness

Acceptable level of protection (cases/yr)Food safety objective

(cfu/g)Performance criteria (logs inactivation)Process criteria (C - min) ICMSF

Microbiological criteria(cfu/g)

Page 16: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Microbiological Criteria

2 4 6 8 10

FSO

MC

Log cfu/g

Considers:Considers:

The process/control The process/control measure and the measure and the sampling and testing sampling and testing methodsmethods

Growth after MC point

Page 17: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Microbiological Criteria

2 4 6 8 10

FSO

MC

Log cfu/g

Page 18: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Sampling to meet FSO

Assume:FSO = 100 CFU/g95% confidence desiredSampling program n = 10, c = 0

Then if: = 0.2, then MC 32 CFU/g = 0.8, then MC 0.86 CFU/g

Page 19: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Establishing FSO, MC & PCs

Conduct risk assessment of food process pathway

Articulate public health goal (e.g., cases/100,000, probability of disease)

Calculate level of exposure that would achieve goal

Evaluate for feasibility (including consideration of variability and uncertainty)

Industry implements food control systems that achieve that level of stringency

Page 20: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Given an FSO Industry would:

Analyze process, conduct detailed process risk assessments (sensitivity analyses, spider plots, scenarios)

Design/select specific process

Choose Performance and Process criteria that achieve MC and FSO

Establishing FSO, MC & PCs

Page 21: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Requires an increased degree of sophistication by government and industrySafe harbors for small processes

Relies on microbial data, modeling and risk assessment

Relating food law to the concepts

Challenges:

Page 22: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

ALOPWill public accept this approach?How set ALOP?

Set byCurrent practicesBest current practicesBest available technologyDesignated standard

Variable for different FoodsPopulations

Challenges:

Page 23: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

FSOCan we rely on DR models?Do we know enough about host

susceptibility, virulence factors and food matrices?

Challenges:

Page 24: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Microbial Criteria and Performance Criteria

Can these calculations be conducted with sufficient accuracy and precision?

Do we have all the necessary data?

Do we know about consumer/food preparer behavior?

How validate the calculation?

How integrate into HACCP program?

Challenges:

Page 25: Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD 301-436-1925 December 10, 2003 2003 SRA Annual Meeting.

Concluding thought:

We have to control foodborne pathogens, therefore, despite all the unknowns, wouldn’t this system be better than the current non-risk assessment approach?

Opinions are by the author and not necessarily FDA policy